跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,085 条关于
“Altuviiio (efanesoctocog alfa)”
全部
3,085
临床试验
2,255
药物
472
机构
15
资讯
343
去年
Hemophilia A and B Pipeline Advances with Novel Therapies in Clinical Trials
去年
EU Approves Pfizer's Hympavzi as First Weekly Subcutaneous Treatment for Severe Hemophilia B
3个月前
FDA Warning Letter to Genzyme Ireland Raises Supply Chain Alarm for Altuviiio Clinical Trials
去年
New Study Highlights Benefits of Maintaining High Factor VIII Levels in Hemophilia A Patients
去年
Sobi Showcases Efanesoctocog Alfa Data from XTEND Phase 3 Program at WFH 2025 Summit
去年
UK MHRA Approves Sobi's Efanesoctocog Alfa for Haemophilia A Treatment
3个月前
Russia Registers First Efanesoctocog Alfa Drug for Haemophilia A as Nanolek Secures EAEU Rights to China's Armocibat
去年
NHS Approves Revolutionary Weekly Treatment for Severe Haemophilia A at £510,000 Per Year
去年
Sobi to Present New Hematology Data at ASH 2024, Highlighting Advances in Rare Blood Disorders
去年
Hemophilia Treatment Advances: Gene Therapy, Prophylaxis, and On-Demand Therapies Highlighted at ASH 2024
第 1 页，共 35 页
上一页
下一页
